CoChat

Ketamine may exert antidepressant effects via suppressing NLRP3 inflammasome to upregulate AMPA receptors

Li, Jia-Mei, Liu, Lin-Lin, Su, Wen-Jun, Wang, Bo, Zhang, Ting, Zhang, Yi, Jiang, Chun-Lei · 2019 · Neuropharmacology
Cited by 67

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

Recent studies have indicated that sub‐anesthetic dose of ketamine exerts rapid antidepressant effects. Upregulation of &agr;‐amino‐3‐hydroxy‐5‐methylisoxazole‐4‐propionic acid (AMPA) receptors contributes to rapid antidepressant effects of ketamine. A recent study indicated that the increasing expression of AMPARs is related to the inhibition of NLRP3 inflammasome. Thus, we postulated that NLRP3 inflammasome might play an important role in ketamine's antidepressant effects. We found that sub‐anesthesia dose of ketamine (10ml/kg) ameliorated LPS‐induced depressive‐like behaviors, including decreased sucrose preference and increased immobility times in the tail suspension test. Ketamine also abrogated LPS‐induced over expression of IL‐1&bgr; and NLRP3 and reversed LPS‐induced down‐regulation of AMPA GluA1 subunits in hippocampi. The selective NLRP3 inflammasome inhibitor Ac‐YVAD‐CMK exhibited similar anti‐inflammatory and antidepressant effects like ketamine. Combination of ketamine and Ac‐YVAD‐CMK showed no enhanced anti‐inflammatory and antidepressant effects than ketamine or Ac‐YVAD‐CMK administration alone. These results indicated that the NLRP3 inflammasome might be an important mediator, through which ketamine could regulate AMPA receptors to exert rapid antidepressant effects. HIGHLIGHTSKetamine, a widely used anesthetic, exerts effective antidepressant action.Ketamine exerts antidepressant effects via increasing AMPA receptors subunit GluA1 expression.NLRP3 inflammasome‐IL‐1&bgr; signaling pathway is a vital factor in the ketamine's antidepressant process.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neuropharm.2018.11.022

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 67

Metadata

Authors
Li, J.-M., Liu, L.-L., Su, W.-J., Wang, B., Zhang, T., Zhang, Y., & Jiang, C.-L.
Venue
Neuropharmacology
Publisher
Elsevier BV
Published
2019-03
Volume
146
Pages
149-153
ISSN
0028-3908 (ISSN-L)
OpenAlex
W2903440886
Cited by
67
References
16
FWCI
1.76
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ketamine may exert antidepressant effects via suppressing NLRP3 inflammasome to upregulate AMPA receptors. https://app.cochat.ai/papers/10.1016/j.neuropharm.2018.11.022
The paper
Li, J.-M., Liu, L.-L., Su, W.-J., Wang, B., Zhang, T., Zhang, Y., & Jiang, C.-L. (2019). Ketamine may exert antidepressant effects via suppressing NLRP3 inflammasome to upregulate AMPA receptors. Neuropharmacology. https://doi.org/10.1016/j.neuropharm.2018.11.022

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.